Dr. Blake A. Robbins, DO

Dr. Robbins practices at Tru-skin Dermatology in Austin, Texas.

Dr. Robbins' NPI, 1184164923, was assigned on February 27, 2017. Dr. Robbins graduated from LECOM - Erie in 2017. Dr. Robbins holds Washington license OP61162867.

Dr. Robbins' primary practice is Tru-skin Dermatology, at 3500 Jefferson St, Austin, TX 78731. The practice phone is (512) 451-0139.

Dr. Robbins' primary practice is Tru-skin Dermatology in Austin, Texas. The medical group on file is Diagnostic Clinic of Longview. Dmand AI also links Dr. Robbins to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Robbins practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Robbins' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Robbins is board certified in dermatology by the AOA Board of Dermatology. Dr. Robbins is licensed in Washington.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, facial skin infection, hives and itchy rashes among the conditions Dr. Robbins treats.

CMS data shows 2,298 Medicare services from Dr. Robbins across 17 procedure codes in 2024, for 502 Medicare patients. Medicare paid $93,021 for them. Every service was in an office.

CMS counts 502 Medicare patients who saw Dr. Robbins in 2024. The largest group is 65 to 74, with 284 patients. 69% of them have high cholesterol, and 66% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Robbins' median patient age at 69, with 51% women.

In 2024, Dr. Robbins wrote 758 Medicare Part D claims for 279 patients. 91% of them were for generic drugs. CMS names the drug for 605 of them, across 11 drugs with 11 or more claims each, at $163,213 in total drug cost. In 2023, CMS named 264 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Robbins for performance year 2024, reported as part of a group. Dr. Robbins accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 371 procedures of skin biopsy by Dr. Robbins, more than 93% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Robbins in 2024. Dr. Robbins' most frequent co-authors are Aaron S. Farberg, MD, Liqiao Ma, MD and Donna April Serure, DO.

CMS Open Payments shows 493 general payments to Dr. Robbins from 26 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $1,250.

Dr. Robbins graduated from LECOM - Erie in 2017. Dr. Robbins is a member of American Osteopathic College of Dermatology.

Dr. Robbins is in network with 22 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.